Users Recommend Hminers Mining Rigs for Fast and Guaranteed ROI
Hminers, a trusted manufacturer of cryptocurrency mining products, has recently hit the headlines with their three multi-algorithm mining rigs. Numerous users have already recommended these products for a guaranteed return on investment within less than a month.
MIAMI, Aug. 25, 2017 (GLOBE NEWSWIRE) -- Hminers continues to strengthen their position in the rapidly growing global industry for cryptocurrencies, with their advanced range of mining rigs. Within a relatively short lifespan in the highly competitive market, three extremely efficient mining rigs from the company have received a promising response from several users. These users suggest that the mining rigs from www.Hminers.com have provided them fast and guaranteed return on their investment.
Ever since its emergence, cryptocurrencies have brought about a paradigm shift in technology that promises to redefine the concept of commerce and payment mechanisms. Cryptocurrency mining is an integral part of this system that refers to a highly technical process by which new cryptocurrencies are created. In addition to cryptography experts, many common people are now showing an inclination towards cryptocurrency mining as a lucrative business avenue. However, unfortunately, the return on investment offered by most of the mining rigs has been rather disappointing.
Hminers is a team of industry experts passionate about pursuing excellence in the field of blockchain technology. In the past, Hminers has earned the distinction of coming up with the world's first 10 nm ASIC Chip. Following the same tradition, the company's three mining rigs H2U Miner, H4U Miner, and Rack Equipped with 5 x H4U are now offering users a guaranteed return on their investment within just one month.
Highlighting his experience with the H4U Miner, a delighted user mentioned, "I was surprised to find out that this miner actually helped me break-even, and start earning profits within a month. I have tried out several other mining rigs prior to this one, and the performance of the H4U Miner has been superior to all of them. This product also helps maximize profits by mining Bitcoin, Litecoin, Ethereum, or Dash as per user preference."
The heart of the advanced mining rigs from Hminers lies within their high hash power rate that makes them the strongest mining rigs available on the market. While designing these products, Hminers has also addressed the common problem of high electric power consumption. Unlike many other products, these mining rigs are built and designed to operate under multiple algorithms, and generate minimum noise and heat during the process of mining.
"While designing our mining rigs, it was our utmost priority to make cryptocurrency mining more lucrative for the users by ensuring the best possible return on investment for them within the least possible time," said the CTO of Hminers, Benjamin Berglung. "The feedback from the users certainly indicates that our efforts have not been wasted."
To find out more about the new Hminers Mining Rigs, please visit https://hminers.com/products/
About Hminers: Hminers is the most recognizable companies in the cryptocurrency industry and the proud creators of the world's first 10 nm ASIC Chip. The core team of this organization comprises of top level specialists from globally renowned organizations such as IBM, Microsoft, and Samsung.Contact:
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hminers via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
Umecrine Cognition announces first patient included in clinical Phase 2a study in patients with sleep disorder20.11.2017 08:00 | Pressmeddelande
STOCKHOLM - November 20, 2017. Umecrine Cognition AB, a Karolinska Development (Nasdaq Stockholm: KDEV) portfolio company, today announces the inclusion of the first patient in a clinical Phase 2a study with the lead compound GR3027 in patients with idiopathic hypersomnia. The objectives of the study (protocol UCAB-CT-03) are to assess the safety and pharmacokinetics, and to evaluate the exploratory efficacy of GR3027 in patients with idiopathic hypersomnia. Idiopathic hypersomnia (IH) is a severe orphan disease characterized by chronic excessive daytime sleepiness (EDS). It is a lifelong debilitating condition with a profound effect on the patient's quality of life. There are no approved treatments for IH but several wake-promoting treatments are used off-label. However, they are inadequate to alleviate symptoms in most patients, and medication-refractory symptoms or medication intolerance prevents control of symptoms in approximately one-quarter of IH patients.
Integrum uppmärsammas av Frankrikes president Emmanuel Macron och Stefan Löfven17.11.2017 19:02 | Pressmeddelande
PRESSINFORMATION 17 november 2017 Integrum blev vid fredagens EU-toppmöte i Göteborg som ett av få inbjudna att presentera bolagets tankestyrda proteser för Frankrikes president Emmanuel Macron och Stefan Löfven. Detta i samband med det strategiska partnerskap för innovation mellan Frankrike och Sverige som undertecknades vid mötet med mål att presentera konkreta framsteg inom två år. Integrum var utvalt som ett bra exempel på innovativt företag som utvecklar avancerade medicintekniska produkter där samspelet mellan människa och teknik skapar stort värde för användaren. Under mötet med president Emmanuel Macron och Stefan Löfven demonstrerades Integrums världsunika proteser som styrs med hjälp av tankekraft. Tekniken möjliggör att personer kan få en protes direkt kopplat till skelett, nerver och muskler utan att ha elektroder tillfälligt fästa utanpå huden. "Det är självklart mycket hedrande att I
CrownBio Launches an Innovative Grant Program to Fund Advancements in Preclinical Oncology Research17.11.2017 18:07 | Pressmeddelande
SANTA CLARA, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the launch of a grant program supporting oncology research scientists which provides funding for projects that show promise for scientific advancement of Patient Derived Xenograft (PDX) technology. Research Grants up to $50,000 will be awarded to projects focused on accelerating the pace of preclinical innovation and novel PDX methodologies that improve clinical predictions with sound science. The program offers an opportunity for investigators to receive funding for projects that may not receive support through traditional funding channels. Submitted proposals will be reviewed and selected by CrownBio's Scientific Steering Committee with the goa
Barings Backs Sentinel Capital Partners in Acquisition of Nekoosa17.11.2017 17:00 | Pressmeddelande
CHARLOTTE, N.C., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Barings, one of the world's leading asset management firms, announced today that it served as Lead Agent on a senior secured credit facility to support Sentinel Capital Partners in its acquisition of Nekoosa ("Nekoosa" or the "Company"). Headquartered in Nekoosa, Wisconsin, the Company is a leading manufacturer of specialty paper and film products used in the graphics and commercial print markets, including application and pressure-sensitive tapes, specialty synthetic papers, sheeted digital and offset grade carbonless paper, and extruded film products. Nekoosa serves a highly diverse base of more than 70,000 commercial print and graphics shops in 65 countries. Barings served as lead senior lender on the transaction, which included a senior term loan and a revolving credit facility. "Sentinel is pleased to have Barings' support on our investment in Nekoosa," said Scott Perry, a partner with Sentinel Capital Partner
At SC17, ExaScaler and PEZY Computing Unveil Gyoukou Supercomputer with a High Combined Green500/Top500 Ranking16.11.2017 23:29 | Pressmeddelande
ExaScaler and PEZY Computing Also Take Top Three Green500 Positions DENVER, Nov. 16, 2017 (GLOBE NEWSWIRE) -- At SC17, ExaScaler and PEZY Computing unveiled their Gyoukou supercomputer whose Green500 and Top500 rankings attest to a unique combination of high efficiency and computing power. The Gyoukou supercomputer is installed at the Yokohama Research Institute in Japan. (Video: PEZY Liquid immersion cooling) PEZY supercomputers leverage 48V Factorized Power, a high efficiency, high density power distribution architecture. PEZY's CPUs are co-packaged with Vicor's Power-on-Package ("PoP") Modular Current Multipliers ("MCMs"), which enable efficient, direct 48V to sub-1V current multiplication at the XPU. ExaScaler and PEZY Computing also achieved the #1, #2 and #3 positions on the Green500. These supercomputer system installations also utilize 48V Factorized Power. Come see us at SC17 at Booth 633 where ExaScaler / PEZY Computing will be
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum